Efficacy and Safety of Risankizumab in Pediatric Patients With Psoriasis: Results From the OptIMMize-1 Phase 3 Study

20260 citationsJournal Articlebronze Open Access

Authors

Good health and well-being

Published in: Journal of Investigative Dermatology

Volume 146, Issue 3, pp. S19-S19

Field-Weighted Citation Impact: 0.00